Results 11 to 20 of about 1,282,511 (265)

Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF©

Orphanet Journal of Rare Diseases, 2021
Background Advanced systemic mastocytosis (AdvSM), indolent systemic mastocytosis (ISM), and smoldering systemic mastocytosis (SSM) are rare diseases characterized by neoplastic mast cell infiltration of more than one organ.
Fiona Taylor, Cem Akin, Roger E. Lamoureux, Brad Padilla, Tanya Green, Anthony L. Boral, Iyar Mazar, Brenton Mar, Alan L. Shields, Frank Siebenhaar   +9 more
doaj   +2 more sources

Cephalalgia against the background of systemic mastocytosis: a clinical case

Бюллетень сибирской медицины, 2021
The article presents a clinical case of comorbid pathology – development of migraine against the background of systemic mastocytosis. The classification and clinical manifestations of systemic mastocytosis, a rare blood disease, are given.This clinical ...
P. I. Kuznetsova, M. M. Tanashyan, A. L. Melikyan, I. N. Subortseva, A. A. Raskurazhev   +4 more
doaj   +3 more sources

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis [PDF]

, 2016
We evaluated the impact of clinical and molecular characteristics on overall survival (OS) in 108 patients with indolent (n=41) and advanced SM (advSM, n=67).
Clemens, J., Cross, N.C.P., Fabarius, A., Hausmann, D., Henzler, T., Hofmann, W.-K., Horny, H.-P., Jawhar, M., Metzgeroth, G., Naumann, N., Reiter, A., Schoenberg, S.O., Schwaab, J., Sotlar, K., Valent, P.   +14 more
core   +3 more sources

P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL, HIGHLY SELECTIVE, POTENT KIT D816V INHIBITOR, IN ADULTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (APEX): METHODS, BASELINE DATA, AND EARLY INSIGHTS

HemaSphere, 2022
Background: Background: Systemic mastocytosis (SM) is a rare disease characterized by accumulation of pathogenic mast cells in bone marrow and extracutaneous tissues with or without skin involvement.
Daniel J. DeAngelo, Vinod Pullarkat, Miguel Piris‐Villaespesa, Tracy I. George, Janaki Patel, Celalettin Üstün, P. Bose, Mark Heaney, A. Pilla, M. Massaro, B. Exter, H. A. Jolin, Z. Mikhak, Tsewang Tashi   +13 more
openalex   +2 more sources

Fire ant-venom anaphylaxis prevalence in the general population and patients with systemic mastocytosis [PDF]

Frontiers in Allergy
BackgroundStinging Hymenoptera can induce fatal anaphylaxis, especially in patients with systemic mastocytosis. Fire ants, Solenopsis invicta and S. richteri, from South America have recently colonized three continents.
Jeremy C. McMurray, Jeremy C. McMurray, Brandon J. Schornack, Brandon J. Schornack, Karla E. Adams, Robert L. McCoy, Amanda K. Marshall, Janet A. Brunader, Irina Maric, Dean D. Metcalfe, Nathan A. Boggs, Nathan A. Boggs   +11 more
doaj   +2 more sources

Using natural language processing to identify symptoms in systemic mastocytosis. [PDF]

JAMIA Open
Xie F, Tse KY, Avila CC, Zhou M, Saparudin M, Atif H, Zeiger RS, Miller K, Powell D, Sullivan E, Lampson B, Puttock EJ, Yuen C, Chen W.   +13 more
europepmc   +3 more sources

Pre-diagnostic and non-advanced systemic mastocytosis without cutaneous involvement have an increased risk of anaphylaxis. [PDF]

Front Allergy
Sangalli A, Pravettoni V, Sciumè M, Consonni D, Sartorio S, Montano N, Rivolta F.   +6 more
europepmc   +3 more sources

Systemic Lymphadenopathic Mastocytosis with Eosinophilia

Diagnostics, 2022
Systemic mastocytosis is a neoplastic proliferation of mast cells that most frequently involves cutaneous sites. Mastocytosis involves various extracutaneous sites, but the lymph node is rare.
Soyoung Im, Jeong-A Kim, Gyeongsin Park, Uiju Cho   +3 more
doaj   +1 more source

Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management

American journal of hematology/oncology, 2023
Systemic mastocytosis (SM) results from clonal proliferation of mast cells (MC) in extracutaneous organs.
A. Pardanani
semanticscholar   +1 more source

Mastocytosis. General concepts, view on patient management, examples of clinical course of the disease

Zdorovʹe Rebenka, 2022
Background. Mastocytosis is a disease characterized by the presence of mast cells in various organs. The skin is affected most often. Almost every patient diagnosed with mastocytosis has skin lesions.
O.L. Statkevych, T.V. Sviatenko
doaj   +1 more source